Central Bank Trust Co Lowers stake in Cardinal Health Inc (CAH)

Cardinal Health Inc (CAH) : Central Bank Trust Co reduced its stake in Cardinal Health Inc by 18.04% during the most recent quarter end. The investment management company now holds a total of 10,927 shares of Cardinal Health Inc which is valued at $834,823 after selling 2,405 shares in Cardinal Health Inc , the firm said in a disclosure report filed with the SEC on Oct 7, 2016.Cardinal Health Inc makes up approximately 0.24% of Central Bank Trust Co’s portfolio.

Other Hedge Funds, Including , Advisory Services Network reduced its stake in CAH by selling 557 shares or 28.59% in the most recent quarter. The Hedge Fund company now holds 1,391 shares of CAH which is valued at $106,272. Cardinal Health Inc makes up approx 0.02% of Advisory Services Network’s portfolio.Chevy Chase Trust Holdings reduced its stake in CAH by selling 12,478 shares or 4.45% in the most recent quarter. The Hedge Fund company now holds 267,705 shares of CAH which is valued at $20,313,455. Cardinal Health Inc makes up approx 0.11% of Chevy Chase Trust Holdings’s portfolio. Independent Portfolio Consultants added CAH to its portfolio by purchasing 375 company shares during the most recent quarter which is valued at $28,455. Cardinal Health Inc makes up approx 0.01% of Independent Portfolio Consultants’s portfolio.Washington Trust Bank reduced its stake in CAH by selling 235 shares or 13.49% in the most recent quarter. The Hedge Fund company now holds 1,507 shares of CAH which is valued at $114,351. Cardinal Health Inc makes up approx 0.03% of Washington Trust Bank’s portfolio.

Cardinal Health Inc closed down -0.31 points or -0.40% at $76.4 with 24,42,415 shares getting traded on Friday. Post opening the session at $76.87, the shares hit an intraday low of $75.86 and an intraday high of $77.12 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, Cardinal Health Inc reported $1.14 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.13. The company had revenue of $31384.00 million for the quarter, compared to analysts expectations of $31167.11 million. The company’s revenue was up 13.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS.

Many Wall Street Analysts have commented on Cardinal Health Inc. Cardinal Health Inc was Downgraded by Goldman to ” Neutral” on Sep 16, 2016.

Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Cardinal Health Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cardinal Health Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.